The differential effect of estrogen, estrogen-progestin and tibolone on coagulation inhibitors in postmenopausal women

By Keramaris N. C.   Christodoulakos G. E.   Lambrinoudaki I. V.   Dalamanga A.   Alexandrou A. P.   Bramis J.   Bastounis E.   Creatsas G. C.  

Climacteric, Vol. 10, Iss. 5, 2007-10 ,pp. : 400-407

Informa Healthcare

Access to resources Recommend Favorite

Prevalence of estrogen or estrogen-progestin hormone therapy use

By Brett K.M.   Reuben C.A.  

Obstetrics and Gynecology, Vol. 102, Iss. 6, 2003-12 ,pp. : 1240-1249

Elsevier

Access to resources Recommend Favorite

Differing effects of low-dose estrogen–progestin therapy and pravastatin in postmenopausal hypercholesterolemic women

By Davis S. R.   Goldstat R.   Newman A.   Berry K.   Burger H. G.   Meredith I.   Koch K.  

Climacteric, Vol. 5, Iss. 4, 2002-12 ,pp. : 341-350

Informa Healthcare

Access to resources Recommend Favorite

Administration of transdermal estrogen without progestin increases the capacity of plasma and serum to stimulate prostacyclin production in human vascular endothelial cells

By Mikkola T.   Viinikka L.   Ylikorkala O.  

Fertility and Sterility, Vol. 73, Iss. 1, 2000-01 ,pp. : 72-74

Elsevier

Access to resources Recommend Favorite

The effect of estrogen plus progestin treatment on sleep: a randomized, placebo-controlled, double-blind trial in premenopausal and late postmenopausal women

By Kalleinen N.   Polo O.   Himanen S. -L.   Joutsen A.   Polo-Kantola P.  

Climacteric, Vol. 11, Iss. 3, 2008-01 ,pp. : 233-243

Informa Healthcare

Access to resources Recommend Favorite